TY - JOUR T1 - Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review JF - medRxiv DO - 10.1101/2020.04.24.20078568 SP - 2020.04.24.20078568 AU - Sina Vakili AU - Amir Savardashtaki AU - Sheida Jamalnia AU - Reza Tabrizi AU - Mohammad Hadi Nematollahi AU - Morteza Jafarinia AU - Hamed Akbari Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/29/2020.04.24.20078568.abstract N2 - Coronavirus disease 2019 (COVID-19), a new type and rapidly spread viral pneumonia, is now producing an outbreak of pandemic proportions. The clinical features and laboratory results of different age groups are different due to the general susceptibility of the disease. The laboratory findings of COVID-19 in pregnant women are also conflicting. Para-clinical investigations including laboratory tests and radiologic findings play an important role in early diagnosis and treatment monitoring of severe acute respiratory syndrome and coronavirus-2 (SARS-CoV-2). The majority of previous reports on the SARS-CoV-2 laboratory results were based on data from the general population and limited information is available based on age difference and pregnancy status. This review aimed to describe the COVID-19 laboratory findings in neonates, children, adults, elderly and pregnant women altogether for the first time. The most attracting and reliable markers of COVID-19 in patients were: normal C-reactive protein (CRP) and very different and conflicting laboratory results regardless of clinical symptoms in neonates, normal or temporary elevated CRP, conflicting WBC count results and procalcitonin elevation in children, lymphopenia and elevated lactate dehydrogenase (LDH) in adult patients, lymphopenia and elevated CRP and LDH in the elderly people and high CRP, leukocytosis and elevated neutrophil ratio in pregnant women.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset of the current study are available from the corresponding author on reasonable request.WBCwhite blood cellCOVID-19coronavirus disease 2019ESRerythrocyte sedimentation rateSARS-CoV-2severe acute respiratory syndrome coronavirus-2CKcreatine kinaseASTaspartate aminotransferaseALTalanine aminotransferaseLDHlactate dehydrogenaseRT-PCRreal-time reverse transcription-polymerase chain reactionARDSacute respiratory distress syndromeCRPC-reactive proteinPTprothrombin timePTTpartial thromboplastin timeBUNblood urea nitrogen ER -